AKR1C3 Inhibitor I, WYE-28, Catalog: 2403

IN STOCK!
US$0.00

3-(3,4-Dihydroisoquinolin2(1H)-ylsulfonyl)benzoic acid

PRODUCT SUMMARY

Alternate Names 3-(3,4-Dihydroisoquinolin2(1H)-ylsulfonyl)benzoic acid

Appearance White solid

Molecular Formula C₁₆H₁₅NO₄S

Molecular Weight 317.36

Purity ≥ 98% by HPLC

Solubility DMSO

SMILES O=S(C1=CC(C(O)=O)=CC=C1)(N2CCC(C=CC=C3)=C3C2)=O

InChi InChI=1S/C16H15NO4S/c18-16(19)13-6-3-7-15(10-13)22(20,21)17-9-8-12-4-1-2-5-14(12)11-17/h1-7,10H,8-9,11H2,(H,18,19)

InChi Key ZGVIUMKHTXKKOX-UHFFFAOYSA-N

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

A highly potent and selective inhibitor of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3. In repeat assays it showed an IC₅₀ of 0.013 ± 0.003 μM for AKR1C3, compared with 20.3 ± 3.8 μM against AKR1C1 and >30 μM against AKR1C2 and AKR1C4. This inhibitor also showed potency in a cellular assay, blocking the ability of AKR1C3 to metabolize a proven substrate. Does not display any COX (cyclooxygenase) inhibition at 10 µM in whole blood assay.